Amid sixth outbreak of Sudan Ebola virus, Ugandans bemoan lack of official communication and fears for the economy.

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress in Q4 2024 advancing its corporate growth strategy through ...

Shares of this vaccine maker have returned -13.6% over the past month versus the Zacks S&P 500 composite's +1% change. The Zacks Medical - Biomedical and Genetics industry, to which Novavax ...

Ugandan officials are preparing to deploy a trial vaccine as part of efforts to stem an outbreak of Ebola in the capital, Kampala KAMPALA, Uganda -- Ugandan officials are preparing to deploy a ...

Ugandan authorities have begun a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in ...

SEVEN people have tested positive and two have died from a highly contagious strain of Ebola in Uganda, as scientists race to develop a lifesaving vaccine. This marks a sharp increase from the two ...

Uganda began a vaccine trial Monday against the Sudan strain of Ebola that has killed one person in the outbreak declared last week. World Health Organization Director-General Tedros Adhanom ...

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it ...

KAMPALA, Uganda — Ugandan officials are preparing to deploy a trial vaccine as part of efforts to stem an outbreak of Ebola in the capital, Kampala, a top health official said Sunday.

Ugandan authorities have begun a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in the outbreak declared last week KAMPALA, Uganda -- Ugandan authorities ...

Ugandan authorities launched on Monday a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one nurse in the capital, Kampala. The 32-year-old male nurse died on ...